Enabling the public's early access to good medicines

An internationally recognized pharmaceutical contract development and manufacturing organization (CDMO) in drug substance development and manufacturing.

Porton PharmaTech is currently undergoing development, with new constructions and facility enhancements underway.

New facilities include space designated for research and development laboratories and a KILOLAB.

One of the key highlights is the on-going green field investment in a multi-purpose PILOT PLANT characterized by different reaction trains and materials of construction (MOCs), to allow the handling of multiple reaction conditions. The plant will also include finishing and packaging suites. The pilot plant accounts for an approximate manufacturing capacity of 20 m³ (OEL ≥1 µg/m³). In the same building, QC laboratories and Process Safety Laboratory will be installed, as well as available expansion areas for R&D.